Journal of Advanced Research Multidisciplinary
Targeting class I HDACs suppresses oncogenic vulnerabilities and potentiates KRAS/MAPK pathway inhibitors in KRAS-mutant cancers
The publisher did not provide an abstract — full text is available via the link below.